About MicroBiopharm Japan
MicroBiopharm Japan is a Healthcare company based in Tokyo (Japan) founded in 2011, and was acquired by Gujarat Themis Biosyn in May 2026. Contract research and discovery services are provided to biopharma firms. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors.
Company details
MicroBiopharm Japan was founded in 2011 and is based in Tokyo, Japan. Contract research services are offered to biopharma companies, focusing on fermentation, strain development, and process optimization. Drug discovery is supported through libraries of microorganisms, P450 compounds for hydroxylation, and vitamin D derivatives. The portfolio encompasses anthracycline analogs, macrolide analogs, calcitriol, paricalcitol, pipecolic acid analogs, vitamin D analogues, and cyclodextrins within the biotechnology sector.
- Headquarters Tokyo, Japan
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website microbiopharm.com
- Acquired by Gujarat Themis Biosyn (May 2026)
- InvestorsToray
& 1 more
- Acquired byGujarat Themis Biosyn
(May 2026)
Funding Insights of MicroBiopharm Japan
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of MicroBiopharm Japan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2011 | Seed | β | Toray Industries | β |
2 investors in total: 2 institutional.
Investors in MicroBiopharm Japan
MicroBiopharm Japan has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Toray and Gujarat Themis Biosyn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of Fibers, plastics, composite materials, optical fibers, resins for 3D printing | 1926 | toray.com | Tokyo, Japan | |
Application development services are provided from Vapi, India. | 1981 | gtbl.in | Vapi, India |
Investor details for MicroBiopharm Japan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MicroBiopharm Japan
3 dated milestones of MicroBiopharm Japan across 15 years, from founding to its latest funding, stage changes and deals.
- Founded MicroBiopharm Japan is founded.
- Funding First funding round.
- Exit Acquired by Gujarat Themis Biosyn.
Web traffic of MicroBiopharm Japan
The website of MicroBiopharm Japan (microbiopharm.com) receives about 1.6K visits a month and ranks #7,946,588 among all websites worldwide, #7,199 in Biotechnology and Pharmaceuticals.
- Monthly visits1.6K
▼ 16% vs previous month
- Global rank#7,946,588
among all websites
- Category rank#7,199
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.8
- Average visit38 sec
- DevicesDesktop 27% Β· Mobile 73%
Websites whose visitors overlap most with MicroBiopharm Japan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bioteclab.co.jp | bioteclab.co.jp | 100% | #5,470,117 | β | |
| carnabio.com | 92% | 21.3K | #1,167,012 | View details | |
| oncolys.com | 92% | 32.2K | #685,223 | View details | |
digital-biology.co.jp | digital-biology.co.jp | 91% | #1,424,425 | β | |
| jba.or.jp | 91% | #1,337,186 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for MicroBiopharm Japan
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Microbiopharm Japan
Complete news archive for MicroBiopharm Japan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicroBiopharm Japan
MicroBiopharm Japan was founded in 2011.
MicroBiopharm Japan is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
MicroBiopharm Japan was founded in 2011 and is based in Tokyo, Japan. Contract research services are offered to biopharma companies, focusing on fermentation, strain development, and process optimization. Drug discovery is supported through libraries of microorganisms, P450 compounds for hydroxylation, and vitamin D derivatives. The portfolio encompasses anthracycline analogs, macrolide analogs, calcitriol, paricalcitol, pipecolic acid analogs, vitamin D analogues, and cyclodextrins within the biotechnology sector.
MicroBiopharm Japan has 2 investors. Key investors include Toray, and Gujarat Themis Biosyn.
Yes. MicroBiopharm Japan was acquired by Gujarat Themis Biosyn in May 2026.

